These facts come from FDA’s list of registered outsourcing facilities, updated November 17, 2026, and from the inspection report FDA posted with it.1 FDA’s warning letters about GLP-1 drugs name this company 1 time; they are listed below.
What does FDA’s record show, in brief?
| Facility | Apothecary Pharma, LLC |
| Location | Cary, North Carolina |
| Type | 503B outsourcing facility |
| Registered since | September 7, 2024 |
| Latest registration | October 21, 2026 |
| Last FDA inspection | September 2, 2026 |
| Inspection dates | — |
| Form 483 | Issued |
| FDA action after the inspection | Open |
| Compounds sterile drugs from bulk | Yes |
| FDA warning letters on GLP-1 drugs | 1 |
Has this facility recalled any drugs?
FDA’s enforcement reports list 2 recalled products from this facility, from September 24, 2026 to September 24, 2026: 2 in Class II. 1 of them name a GLP-1 drug. Class I is the most serious: FDA uses it when the product could cause serious harm.3
| Started | Class | Product | Reason |
|---|---|---|---|
| 2026-09-24 | II | Tirzepatide Injection | Lack of Assurance of Sterility |
| 2026-09-24 | II | Apothecary NAD+ Injection 200 mg/mL | Lack of Assurance of Sterility |
Which FDA warning letters name this company?
Is the pharmacy behind my prescription on FDA’s list?
Type a pharmacy name or city. The search runs over all 100 facilities on FDA’s list; a 503A pharmacy that compounds for individual prescriptions is licensed by its state and is not on this list.
Where are the registered outsourcing facilities?
1 of the 100 facilities on FDA’s list are in North Carolina. The chart counts them by state; choose a view to see which ones FDA has inspected.
Which other facilities are in the same state?
What does it mean that a pharmacy is a 503B outsourcing facility?
An outsourcing facility is a compounder that has chosen to register with FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. It must re-register every year between October 1 and December 31 and pay an annual fee; a facility that does not is removed from FDA’s list on January 1.1 Once registered, it joins the list of facilities FDA plans to inspect on a risk-based schedule.1
A Form FDA 483 lists what investigators observed during an inspection. FDA states that a 483 is issued when investigators see significant objectionable conditions, and that it is not a final agency determination that the law was broken.1 Registration is not FDA approval of the drugs a facility makes: compounded drugs are not FDA-approved.
Sources
- FDA. Facilities registered as human drug compounding outsourcing facilities under section 503B, updated November 17, 2026, with its notes on registration and inspections. fda.gov
- FDA. Registered outsourcing facilities: inspection status of Apothecary Pharma, LLC. fda.gov
- FDA. Drug recall enforcement reports for Apothecary Pharma, LLC, read through openFDA on November 20, 2026. open.fda.gov
Log every dose in mg with the vial it came from, so there is a record if something goes wrong.
Open Dose Insider